ColleenElizabethAnnesleyMD

PubMed

• 3 citations
  INSPIRED Symposium Part 2: Prevention and Management of Relapse Following Chimeric Antigen Receptor T Cell Therapy for B Cell Acute Lymphoblastic Leukemia.
  Adam J Lamble, Amy Moskop, Michael A Pulsipher, Shannon L Maude, Corinne Summers, Colleen Annesley, André Baruchel, Lia Gore, Persis Amrolia, Nirali Shah> ;Transplantation and Cellular Therapy. 2023 Nov 1
• 2 citations
  Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure.
  Elizabeth M Holland, Bonnie Yates, Seth M Steinberg, Constance M Yuan, Hao-Wei Wang, Colleen Annesley, Haneen Shalabi, David Stroncek, Terry J Fry, Joerg Krueger, Elad...> ;Transplantation and Cellular Therapy. 2023 Sep 1
• 3 citations
  GFAP and NfL increase during neurotoxicity from high baseline levels in pediatric CD19-CAR T-cell patients.
  Juliane Gust, Stephanie D Rawlings-Rhea, Ashley L Wilson, Niklas M Tulberg, Amber L Sherman, Kristy D Seidel, Qian Vicky Wu, Julie R Park, Rebecca A Gardner, Colleen E...> ;Blood Advances. 2023 Mar 28
• 48 citations
  Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells.
  Adam J Lamble, Regina M Myers, Agne Taraseviciute, Samuel John, Bonnie Yates, Seth M Steinberg, Jennifer Sheppard, Alexandra E Kovach, Brent Wood, Michael J Borowitz, ...> ;Blood Advances. 2023 Feb 28
• 1 citations
  Plasticity of lineage switch in B-ALL allows for successful rechallenge with CD19-directed immunotherapy.
  Brittany M Lee, Corinne Summers, Karen M Chisholm, Sandra D Bohling, Kasey J Leger, Rebecca Gardner, Colleen Annesley, Adam J Lamble> ;Blood Advances. 2023 Jun 27
• 2 citations
  Potential clinical use of azacitidine and MEK inhibitor combination therapy in PTPN11-mutated juvenile myelomonocytic leukemia.
  Santhosh Kumar Pasupuleti, Karen Chao, Baskar Ramdas, Rahul Kanumuri, Lakshmi Reddy Palam, Sheng Liu, Jun Wan, Colleen Annesley, Mignon L Loh, Elliot Stieglitz, Michae...> ;Molecular Therapy. 2023 Apr 5
• 6 citations
  Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy.
  Emily M Hsieh, Regina M Myers, Bonnie Yates, Colleen Annesley, Samuel John, Agne Taraseviciute, Seth M Steinberg, Jennifer Sheppard, Perry Chung, Lee Chen, Daniel W Le...> ;Blood Advances. 2022 Sep 13
• 2 citations
  Chimeric Antigen Receptor T-cell Therapy: Current Status and Clinical Outcomes in Pediatric Hematologic Malignancies.
  Aimee C Talleur, Regina Myers, Colleen Annesley, Haneen Shalabi> ;Hematology/oncology Clinics of North America. 2022 Aug 1
• 5 citations
  Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult Subjects.
  Francesco Ceppi, Ashley L Wilson, Colleen Annesley, Gabriella R Kimmerly, Corinne Summers, Adam Brand, Kristy Seidel, Qian Vicky Wu, Adam Beebe, Christopher Brown, Ste...> ;Cancer Immunology Research. 2022 Jul 1
• 14 citations
  Anakinra utilization in refractory pediatric CAR T-cell associated toxicities.
  Caroline Diorio, Anant Vatsayan, Aimee C Talleur, Colleen Annesley, Jennifer J Jaroscak, Haneen Shalabi, Amanda K Ombrello, Michelle Hudspeth, Shannon L Maude, Rebecca...> ;Blood Advances. 2022 Jun 14
• 84 citations
  Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL.
  Regina M. Myers, Agne Taraseviciute, Seth M. Steinberg, Adam J. Lamble, Jennifer Sheppard, Bonnie Yates, Alexandra E. Kovach, Brent L. Wood, Michael J. Borowitz, Marya...> ;Journal of Clinical Oncology. 2021 Nov 12
• 26 citations
  Hematopoietic Cell Transplantation after CD19 Chimeric Antigen Receptor T Cell-Induced Acute Lymphoblastic Lymphoma Remission Confers a Leukemia-Free Survival Advantage.
  Corinne Summers, Qian Vicky Wu, Colleen Annesley, Marie Bleakley, Ann Dahlberg, Prabha Narayanaswamy, Wenjun Huang, Jenna M. Voutsinas, Adam Brand, Wendy M. Leisenring...> ;Transplantation and Cellular Therapy. 2021 Oct 10
• 40 citations
  Beyond the storm — subacute toxicities and late effects in children receiving CAR T cells
  Haneen Shalabi, Juliane Gust, Agne Taraseviciute, Pamela L. Wolters, Allison Barz Leahy, Carlos Sandi, Theodore W. Laetsch, Lori Wiener, Rebecca Gardner, Veronique Nus...> ;Nature Reviews. Clinical Oncology. 2021 Jan 25
• 11 citations
  Allopurinol use during pediatric acute lymphoblastic leukemia maintenance therapy safely corrects skewed 6-mercaptopurine metabolism, improving inadequate myelosuppres...
  Gordon Cohen, Stacy Cooper, Edward Allan R. Sison, Colleen Annesley, Mariam Bhuiyan, Patrick Brown> ;Pediatric Blood & Cancer. 2020 Nov 1
• 87 citations
  Pediatric acute lymphoblastic leukemia, version 2.2020
  Patrick A. Brown, Hiroto Inaba, Colleen Annesley, Jill C. Beck, Susan Colace, Mari Dallas, Kenneth B. DeSantes, Kara M. Kelly, Carrie L. Kitko, Norman J. Lacayo, Nicol...> ;Journal of the National Comprehensive Cancer Network. 2020 Jan 1
• 14 citations
  EEG Correlates of Delirium in Children and Young Adults With CD19-Directed CAR T Cell Treatment-Related Neurotoxicity
  Juliane Gust, Colleen Annesley, Rebecca Gardner, Xiuhua Bozarth> ;Journal of Clinical Neurophysiology. 2019 Dec 13
• 160 citations
  Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy.
  Rebecca Gardner, Francesco Ceppi, Julie Rivers, Colleen Annesley, Corinne Summers, Agne Taraseviciute, Juliane Gust, Kasey J. Leger, Katherine Tarlock, Todd M. Cooper,...> ;Blood. 2019 Dec 12
• 5 citations
  Knock-In of the Wt1 R394W mutation causes MDS and cooperates with Flt3/ITD to drive aggressive myeloid neoplasms in mice
  Colleen Annesley, Cara A Rabik, Amy S. Duffield, Rachel E. Rau, Daniel Magoon, Li Li, Vicki Huff, Donald Small, David M. Loeb, Patrick Brown> ;Oncotarget. 2018 Oct 19
• 58 citations
  Lymphocyte apheresis for chimeric antigen receptor T-cell manufacturing in children and young adults with leukemia and neuroblastoma.
  Francesco Ceppi, Julie Rivers, Colleen Annesley, Navin Pinto, Julie R. Park, Catherine Lindgren, Stephanie Mgebroff, Naomi Linn, Meghan Delaney, Rebecca Gardner> ;Transfusion. 2018 Jun 1
• 24 citations
  The Evolution and Future of CAR T Cells for B-Cell Acute Lymphoblastic Leukemia.
  Colleen Annesley, Corinne Summers, Francesco Ceppi, Rebecca Gardner> ;Clinical Pharmacology and Therapeutics. 2018 Apr 1
• 728 citations
  Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults.
  Rebecca Gardner, Olivia Finney, Colleen Annesley, Hannah Brakke, Corinne Summers, Kasey J. Leger, Marie Bleakley, Christopher Brown, Stephanie Mgebroff, Karen S. Kelly...> ;Blood. 2017 Jun 22
• 50 citations
  A Phase I Study of Quizartinib Combined With Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study
  Todd M. Cooper, Jeannette Cassar, Elena Eckroth, Jemily Malvar, Richard Sposto, Paul S. Gaynon, Bill H. Chang, Lia Gore, Keith J. August, Jessica A. Pollard, Steven G....> ;Clinical Cancer Research. 2016 Aug 15
• 25 citations
  POL5551, a novel and potent CXCR4 antagonist, enhances sensitivity to chemotherapy in pediatric ALL.
  Edward Allan R. Sison, Daniel Magoon, Li Li, Colleen Annesley, Barbara Romagnoli, Garry Douglas, Gerald Tuffin, Johann Zimmermann, Patrick Brown> ;Oncotarget. 2015 Sep 3
• 40 citations
  Novel agents for the treatment of childhood acute leukemia
  Colleen Annesley, Patrick Brown> ;Therapeutic Advances in Hematology. 2015 Jan 29
• 48 citations
  The Biology and Targeting of FLT3 in Pediatric Leukemia.
  Colleen Annesley, Patrick Brown> ;Frontiers in Oncology. 2014 Sep 23
• Join now to see all

Lectures

• Clinical Experience of CAR T Cell Immunotherapy for Relapsed and Refractory Infant ALL Demonstrates Feasibility and Favorable Responses 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019